Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Completed Successful FDA Meeting for DCCR in Prader-Willi Syndrome Preparing to begin Phase III program by the end of the year Monetized Non-Strategic Assets Through Sale of NeoForce, Inc. Subsidiary REDWOOD CITY, Calif., Aug. 11, 2017 (GLOBE NEWSWIRE) -- …